Diet and genetic risk for prostate cancer (Results from Carotene and Retinol Efficacy Trial = CARET)

Cancer Prevention Program

Diet and Genetic Risk for Prostate Cancer

This study investigates comprehensive measures of diet and dietary supplements with a focus on antioxidants measured by both self-reported and blood based biomarkers of intake in relation to prostate cancer risk among 12,000 participants in the Carotene and Retinol Efficacy Trial (CARET). We also measured polymorphisms in oxidative stress regulatory genes and whether any diet gene interactions modify associations of diet and nutritional biomarkers with prostate cancer risk.  

Marian Neuhouser, PHD, RD

Marian Neuhouser, PHD, RD
Program Head, Cancer Prevention Program  

More Information

Funding Agency:
National Cancer Institute  

Diana Lowry